BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Decrease in Short Interest

BioRestorative Therapies, Inc. (NASDAQ:BRTX) was the target of a large decrease in short interest in November. As of November 30th, there was short interest totalling 66,900 shares, a decrease of 10.1% from the November 15th total of 74,400 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average daily volume of 50,000 shares, the days-to-cover ratio is presently 1.3 days.

BioRestorative Therapies Trading Up 0.7 %

Shares of BioRestorative Therapies stock traded up $0.01 on Monday, hitting $1.46. 12,222 shares of the company traded hands, compared to its average volume of 710,102. The firm’s 50-day simple moving average is $1.55 and its 200 day simple moving average is $1.62. The company has a market cap of $10.10 million, a P/E ratio of -0.91 and a beta of 62.52. BioRestorative Therapies has a 12-month low of $1.03 and a 12-month high of $3.67.

BioRestorative Therapies (NASDAQ:BRTX) last issued its earnings results on Tuesday, November 12th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.22. The company had revenue of $0.23 million for the quarter, compared to analysts’ expectations of $0.30 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. Analysts predict that BioRestorative Therapies will post -1.43 earnings per share for the current year.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.